SENS: Senseonics Holdings, Inc.
Performance
SENS +63.06%
Watchlist
Select an item
Summary
SENS at a glance
SENS returned +63.06% over the past year and -33.64% a year over five years. Its worst drop in that year was -41.80%, smaller than 34% of stocks on Redstone, and its Sharpe ratio of 0.96 beats 73% of stocks on Redstone. It pays no dividends.
Current Drawdown
-5.22%
Rolling Volatility
105.69%
Actions
Metrics
Risk Indicators
Alpha54.64%
Beta2.39x
Sharpe0.96
Sortino1.50
Omega1.20
Calmar1.51
Martin3.85
Profile
About SENS
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy.
- Sector
- Health Care
- Industry
- Industrial Instruments for Measurement, Display, and Control
- Market cap
- $518M
- Listed
- Mar 2016
- Employees
- 130
- Headquarters
- Germantown, MD
- Website
- senseonics.com
Comparisons